Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q3

3034.TEDINET S100Q6EO
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥126.1bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥166.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥124.5bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥6.8bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥6.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥7.1bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥10.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.1bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥7.1bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥7.1bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥4.2bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥105.5bnat 2022-12-31Cons.Assets
Total assets¥96.0bnat 2022-03-31Cons.Assets
Total assets¥103.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥58.3bnat 2022-12-31Cons.Liabilities
Total liabilities¥52.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥47.3bnat 2022-12-31Cons.Net assets
Net assets / equity¥43.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥42.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥26.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥16.7bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥112.572022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.432022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.512021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥113.262021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.262021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio44.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio41.1%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥2.6bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥115.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥115.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥66m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥11.1bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥250m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
—segment totalrevenue2022-04-01 → 2022-12-31¥126.4bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥126.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥317m
—segment totalsegment profit2022-04-01 → 2022-12-31¥9.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥308m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥308m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥2.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2021-04-01 → 2021-12-31¥114.9bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2021-04-01 → 2021-12-31¥114.9bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥46m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2021-04-01 → 2021-12-31¥8.4bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-12-31¥9.9bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-12-31¥9.7bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥261m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-12-31¥930m
—segment totalrevenue2021-04-01 → 2021-12-31¥124.9bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥124.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥308m
—segment totalsegment profit2021-04-01 → 2021-12-31¥9.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 367
ItemContextValueUnit
Gain on sales of investment securities eiPrior1YTDDuration0JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Gain on reversal of provision for withdraw loss from employees pension fund eiPrior1YTDDuration71000000JPY
Gain on reversal of provision for withdraw loss from employees pension fund eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration74000000JPY
Extraordinary incomeCurrentYTDDuration6000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration32000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration29000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration0JPY
Loss on sales of noncurrent assets elCurrentYTDDuration3000000JPY
Loss on valuation of subsidiaries stocks elPrior1YTDDuration49000000JPY
Loss on valuation of subsidiaries stocks elCurrentYTDDuration－JPY
Loss on sales of subsidiaries stocks elPrior1YTDDuration5000000JPY
Loss on sales of subsidiaries stocks elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration88000000JPY
Extraordinary lossCurrentYTDDuration33000000JPY
Income before income taxesPrior1YTDDuration7057000000JPY
Income before income taxesCurrentYTDDuration7068000000JPY
Income taxesPrior1YTDDuration2900000000JPY
Income taxesCurrentYTDDuration2908000000JPY
Profit lossPrior1YTDDuration4156000000JPY
Profit lossCurrentYTDDuration4159000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration1000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration1000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration4155000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration4158000000JPY
Profit lossPrior1YTDDuration4156000000JPY
Profit lossCurrentYTDDuration4159000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-17000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration0JPY
Other comprehensive incomePrior1YTDDuration-17000000JPY
Other comprehensive incomeCurrentYTDDuration0JPY
Comprehensive incomePrior1YTDDuration4139000000JPY
Comprehensive incomeCurrentYTDDuration4160000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration4138000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration4158000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember114889000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember9655000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember124545000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration124545000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember46000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember261000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember308000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-308000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember114936000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember9917000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass